Yanpeng Hao

Nanjing Jiangning Hospital

Papers

1

Total Citations

16

H-Index

1

About

Dr. Yanpeng Hao is a translational researcher specializing in gynecological oncology, with a primary focus on patient-derived tumor xenograft (PDTX) models. Their most cited work, "Establishment of the PDTX model of gynecological tumors" (2019, 16 citations), represents a significant methodological contribution to preclinical cancer research. In this study, Dr. Hao successfully transplanted fresh tumor tissues from 15 patients with gynecological tumors into immunodeficient NCG mice, creating a robust platform for personalized medicine. This achievement is notable for its practical approach to preserving the genetic and histological characteristics of original tumors, enabling more accurate drug sensitivity testing and biomarker discovery. The work addresses a critical gap in gynecological cancer research, where reliable preclinical models are essential for translating laboratory findings into clinical applications. Dr. Hao’s research has implications for improving treatment strategies for ovarian, cervical, and endometrial cancers, offering a pathway toward more individualized therapeutic interventions. Their contributions continue to influence the field of tumor modeling and precision oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
16
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
Establishment of the PDTX model of gynecological tumors.
16 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Nanjing Jiangning Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago